Karen Jean Ferrante - May 19, 2022 Form 4 Insider Report for MACROGENICS INC (MGNX)

Role
Director
Signature
/s/ Lynn Cilinski, Attorney-in-Fact
Stock symbol
MGNX
Transactions as of
May 19, 2022
Transactions value $
$0
Form type
4
Date filed
5/23/2022, 09:06 PM
Previous filing
Apr 5, 2022
Next filing
Jun 9, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNX Stock Option (right to buy) Award $0 +18K $0.00 18K May 19, 2022 Common Stock 18K $3.90 Direct F1
transaction MGNX Stock Option (right to buy) Award $0 +20.6K $0.00 20.6K May 19, 2022 Common Stock 20.6K $3.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.
F2 At the election of the filing person, the option grant is issued in lieu of direct cash compensation of such person's annual retainer through the Company's non-employee director compensation program and will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards to whole shares) beginning one month from the date of grant.